Nykredit A S Takes $8.79 Million Position in Agilent Technologies, Inc. $A

Key Points

• Nykredit A/S acquired 66,134 Agilent Technologies shares during the second quarter, building a position worth approximately $8.79 million. Institutional investors collectively own 87.41% of the company.
• Agilent reported quarterly earnings of $1.62 per share and revenue of $1.88 billion, beating analyst expectations; revenue increased 8.1% year over year. The company guided to fiscal 2026 EPS of $6.18–$6.21.
• Analysts maintain a generally positive outlook, with the stock carrying a “Moderate Buy” consensus rating and a $170.33 average price target. Agilent also declared a quarterly dividend of $0.255 per share, representing a 0.7% annualized yield.

Nykredit A S acquired a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 66,134 shares of the medical research company's stock, valued at approximately $8,785,000.

Several other large investors have also made changes to their positions in A. Allianz Asset Management GmbH grew its holdings in Agilent Technologies by 11.8% in the 2nd quarter. Allianz Asset Management GmbH now owns 400,557 shares of the medical research company's stock valued at $53,206,000 after buying an additional 42,380 shares during the last quarter. Corient Private Wealth LP increased its position in Agilent Technologies by 8.5% during the second quarter. Corient Private Wealth LP now owns 240,532 shares of the medical research company's stock worth $31,952,000 after acquiring an additional 18,901 shares during the period. Amundi increased its position in Agilent Technologies by 20.3% during the second quarter. Amundi now owns 1,294,098 shares of the medical research company's stock worth $171,891,000 after acquiring an additional 218,514 shares during the period. HighTower Advisors LLC raised its stake in Agilent Technologies by 3.3% during the 2nd quarter. HighTower Advisors LLC now owns 176,828 shares of the medical research company's stock valued at $23,488,000 after purchasing an additional 5,710 shares during the last quarter. Finally, Wedmont Private Capital raised its stake in Agilent Technologies by 10.8% during the 2nd quarter. Wedmont Private Capital now owns 5,599 shares of the medical research company's stock valued at $752,000 after purchasing an additional 547 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company's stock.

Insiders Place Their Bets

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business's stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares of the company's stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.17% of the company's stock.

Agilent Technologies Trading Down 0.1%

A stock opened at $156.24 on Monday. The business has a fifty day moving average price of $145.79 and a 200 day moving average price of $129.73. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The stock has a market capitalization of $44.05 billion, a price-to-earnings ratio of 30.76, a P/E/G ratio of 2.38 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company had revenue of $1.88 billion for the quarter, compared to analysts' expectations of $1.84 billion. During the same quarter in the prior year, the business earned $1.37 earnings per share. The business's revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be issued a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies's dividend payout ratio is currently 20.08%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Stifel Nicolaus increased their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a "buy" rating in a report on Thursday, August 27th. UBS Group assumed coverage on shares of Agilent Technologies in a report on Wednesday, September 9th. They set a "neutral" rating and a $165.00 price objective on the stock. Weiss Ratings raised shares of Agilent Technologies from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, September 11th. Piper Sandler began coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They issued a "neutral" rating and a $150.00 target price for the company. Finally, The Goldman Sachs Group lifted their target price on Agilent Technologies from $155.00 to $175.00 and gave the stock a "buy" rating in a research report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $170.33.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.